Journal
NEUROCHEMICAL RESEARCH
Volume 36, Issue 11, Pages 2096-2103Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-011-0533-z
Keywords
Alzheimer's disease; Amyloid beta-protein; Apoptosis; Cytotoxicity; Oxidative stress; Walnut
Categories
Funding
- New York State Office for People with Developmental Disabilities
- California Walnut Commission
Ask authors/readers for more resources
Amyloid beta-protein (A beta) is the major component of senile plaques and cerebrovascular amyloid deposits in individuals with Alzheimer's disease. A beta is known to increase free radical production in neuronal cells, leading to oxidative stress and cell death. Recently, considerable attention has been focused on dietary antioxidants that are able to scavenge reactive oxygen species (ROS), thereby offering protection against oxidative stress. Walnuts are rich in components that have anti-oxidant and anti-inflammatory properties. The inhibition of in vitro fibrillization of synthetic A beta, and solubilization of preformed fibrillar A beta by walnut extract was previously reported. The present study was designed to investigate whether walnut extract can protect against A beta-induced oxidative damage and cytotoxicity. The effect of walnut extract on A beta-induced cellular damage, ROS generation and apoptosis in PC12 pheochromocytoma cells was studied. Walnut extract reduced A beta-mediated cell death assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction, and release of lactate dehydrogenase (membrane damage), DNA damage (apoptosis) and generation of ROS in a concentration-dependent manner. These results suggest that walnut extract can counteract A beta-induced oxidative stress and associated cell death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available